We offer a comprehensive range of pain management solutions that enable you to respond effectively to the individual requirements of each patient.
We focus on supporting the NHS in managing conditions like chronic pain.
Around 14 million people in the UK, both children and adults suffer with persistent/chronic pain,1 resulting in a major impact on their quality of life and inability to maintain regular work.
Most patients with chronic pain can be well managed in the community or local hospitals by appropriately trained members of interdisciplinary Pain Management Services; however, some patients with more complex chronic pain problems require management in highly specialised Pain Management centres.
Breakthrough cancer pain affects cancer patients who already experience controlled every day pain. It comes on suddenly and quickly, often without warning, it is usually short-lived – typically lasting about 30-60 minutes, although the episodes can vary.
Oncology nurses have an important role in identifying and managing breakthrough cancer pain and in referring difficult cases to Pain Specialists.
1 https://www.england.nhs.uk/wp-content/uploads/2013/06/d08-spec-serv-pain-mgt.pdf [accessed 17.04.18].
2 Effentora® (fentanyl buccal tablet) Summary of Product Characteristics.
3 Actiq® (oral transmucosal fentanyl citrate) Summary of Product Characteristics.
4 Axsain® (capsaicin cream 0.075%) Summary of Product Characteristics.
5 Zacin® (capsaicin cream 0.025%) Summary of Product Characteristics.
To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.